Effects of Enteral Nutrition Content on Disease Progression in Sepsis Patients

NCT06943326 · tracked via the Priya Life Science Turkey tracker

Sponsor

Inonu University

Phase

Observational

Started

2024-11-01

Last updated

2025-04-24

Condition(s) studied

SepsisNutritional Deficiency

Investigational drug(s) / intervention(s)

nutrition monitoring

nutrition monitoring: There is no investigator intervention in the study. Patients' nutrition is recorded for one week from the beginning of the study.

Study summary

The aim of this study was to investigate the effects of enteral nutrition content on disease progression in sepsis patients.

Eligibility

Sex

ALL

Min age

18 Years

Max age

—

Healthy volunteers

Inclusion Criteria: * Being diagnosed with sepsis and being able to receive enteral nutrition 24 hours after starting treatment in the intensive care unit Exclusion Criteria: * chronic liver disease, chronic renal failure, active cancer or parenteral nutrition

Primary outcome measure(s)

Change in Serum Glucose Level — Baseline and Day 7
Change in fasting blood glucose level (mg/dL) from baseline to Day 7.
Change in Serum Albumin Level — Baseline and Day 7
Change in serum albumin concentration (g/dL) from baseline to Day 7.
Change in Serum C-Reactive Protein (CRP) Level — Baseline and Day 7
Change in serum CRP level (mg/L) from baseline to Day 7.
Change in Hemoglobin Level — Baseline and Day 7
Change in hemoglobin concentration (g/dL) from baseline to Day 7.
Change in Serum Urea Level — Baseline and Day 7
Change in serum urea concentration (g/dL) from baseline to Day 7.
Change in Serum Creatinine Level — Baseline and Day 7
Change in serum creatinine concentration (g/dL) from baseline to Day 7.
Change in Absolute Lymphocyte Count — Baseline and Day 7
Change in absolute lymphocyte count () from baseline to Day 7.
Change in Total Leukocyte Count — Baseline and Day 7
Change in total leukocyte count (10\^3/µL) from baseline to Day 7.
Change in Monocyte Count — Baseline and Day 7
Change in absolute monocyte count (10\^3/µL) from baseline to Day 7.
Change in Neutrophil Count — Baseline and Day 7
Change in absolute neutrophil count (10\^3/µL) from baseline to Day 7.
Change in Eosinophil Count — Baseline and Day 7
Change in absolute eosinophil count (10\^3/µL) from baseline to Day 7.
Change in Basophil Count — Baseline and Day 7
Change in absolute basophil count (10\^3/µL) from baseline to Day 7.

Trial sites (1)

Facility	City	Region	Status
Mehmet Akif Inan Training and Research Hospital	Sanliurfa	Turkey (Türkiye)	Recruiting

More Inonu University trials in Turkey

Effect of Augmented Low-dye* Taping and Exercise on Plantar Pressure, Navicular Drop and Foot Posture in Pes Planus Active, not recruiting

Liver Transplant Recipients and 30-Second Lie-to-Sit Test Recruiting

Blood Parameter Changes Following Aerobic Exercise in Professional Soccer Players Starting soon

The Effect of Web-based Education on Gynecological Cancer Awareness and Healthy Life Behaviors Enrolling by invitation

Nonpharmacological Management of Pain and Fear During Hormone Injection in Breast Cancer Patients Starting soon

Other trials for the same condition

Normal Saline Versus Ringer's Lactate for Initial Fluid Resuscitation in Sepsis Starting soon

Cortisol Levels and Mortality in Septic Shock ICU Patients Recruiting

Comparison of NEWS2 and Machine Learning for Early Sepsis Warning Active, not recruiting

Can Gdf-15 Level Predict Progression to Multiple Organ Failure in Patients With Septic Shock Enrolling by invitation

IL-40 and IL-41 Levels in Sepsis, Septic Shock, and Healthy Individuals Starting soon

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06943326 on ClinicalTrials.gov ↗ ← All trials in Turkey